Brief Report
15 September 2012

Competitive Incorporation of Homologous Gene Segments of Influenza A Virus into Virions

ABSTRACT

By using two reporter protein-encoding virus-like RNAs derived from identical viral RNA (vRNA) segments, we assessed their incorporation efficiency into single progeny virions. Most plaques formed by the recombinant viruses that were generated in cells positive for both reporter genes expressed only one or the other protein. These results suggest that two virus-like RNAs encoding different reporter proteins compete for incorporation into virions, and individual influenza virions incorporate single, but not multiple, copies of homologous vRNA segments.

TEXT

The influenza A virus genome is segmented into eight negative-sense RNAs. Although this segmented genome allows viruses to evolve rapidly through gene reassortment, all of the eight viral RNA (vRNA) segments need to be introduced into a cell for the viruses to be infectious (18). In virions, eight kinds of RNA molecules were detected at a comparable molar ratio in purified viruses (17). Previously, we used electron microscopy to show that eight rods, which were most likely vRNA-associated ribonucleoprotein complexes (RNPs), were packed in budding virions in an orderly fashion (12). Further, the three-dimensional structure of the RNPs revealed that the eight rod-like structures were of different lengths and well organized but asymmetrically arranged in progeny virions (2, 13). These findings suggest that the individual influenza virions incorporate eight vRNA segments; however, it remains unclear whether the eight rods correspond to the eight genetically distinct vRNA segments (i.e., the eight distinct vRNA segments are present in individual virions) or some rods are genetically identical (i.e., multiple copies of homologous vRNA segments are packaged in individual virions and the eight vRNA segments are maintained as virus populations).
We therefore attempted to assess the incorporation efficiency of two reporter protein-encoding virus-like RNAs derived from identical vRNA segments. We (3, 4, 10, 1315) and others (1, 59) have reported that the noncoding and coding sequences at the 3′ and 5′ ends of each vRNA segment are essential for efficient segment incorporation into virions. According to these findings, we constructed a plasmid encoding two RNA polymerase I promoter-driven transcription cassettes for virus-like RNA expression (Fig. 1A to C). One transcription cassette produces negative-sense RNA containing the 3′ noncoding sequence of the neuraminidase (NA) vRNA segment, 183 nucleotides of the 3′ coding sequence of the NA vRNA segment, the open reading frame of green fluorescent protein (GFP; Clontech), 157 nucleotides of the 5′ coding sequence of the NA vRNA segment, and the 5′ noncoding sequence of the NA vRNA segment (Fig. 1A). Another cassette produces the same virus-like RNA except that the GFP reporter gene was replaced with the gene encoding DsRed-monomer fluorescent protein (DsRed; Clontech) (Fig. 1B). The length of the coding sequence at each end is required for efficient incorporation of the NA vRNA segment (4). To ensure that the two virus-like vRNAs encoding different reporter proteins were produced in the same cells, we constructed plasmids containing the two transcription cassettes. Further, to eliminate any effect of gene order in the plasmid on the expression level of the virus-like RNAs, we prepared two types of plasmids containing the two transcription cassettes in a different order (Fig. 1C).
Fig 1
Fig 1 Competitive incorporation of the NA vRNA segment into virions. (A to C) Schematic diagram of influenza virus-like RNA constructs. Transcription cassettes for GFP (green bar in panel A) and DsRed (red bar in panel B) genes flanked by the 3′ and 5′ noncoding (white bars) and coding (gray bars) sequences of the NA vRNA segment were cloned into RNA polymerase I promoter-driven plasmids for the expression of influenza virus-like RNA (11) in different configurations (panel C). (D) Ratio of fluorescent protein-expressing plasmid-transfected cells. 293T cells were transfected with NA vRNA segment-derived tandem reporter plasmids together with protein expression plasmids required for vRNA transcription and replication. At 24 h posttransfection, cells positive for GFP only (green bar), DsRed only (red bar), and both GFP and DsRed (yellow) were counted under a fluorescence microscope. Mean ratios of each cell population calculated from three independent experiments are shown. (E) Ratio of fluorescent protein-expressing virus-formed plaques. MDCK cells were infected with NA-knockout viruses generated in cells that were transfected with an NA vRNA segment-derived tandem reporter plasmid, and plaque assays were performed. At 24 h postinfection, plaques positive for GFP only (green bar), DsRed only (red bar), and both GFP and DsRed (yellow) were counted under a fluorescence microscope. Mean ratios of each plaque population calculated from three independent experiments are shown.
To confirm that the resultant “tandem” reporter plasmids indeed produced both GFP- and DsRed-encoding virus-like RNAs in cells, 293T cells were transfected with the plasmids together with four protein plasmids for the expression of the A/WSN/33 (H1N1, WSN) viral polymerase subunits (PB2, PB1, and PA) and nucleoprotein NP, which are required for vRNA transcription and replication (18). At 24 h posttransfection, GFP- and/or DsRed-expressing cells were counted under a fluorescence microscope. Approximately half (45.7%) of the fluorescent protein-positive cells expressed both GFP and DsRed (Fig. 1D).
Next, to assess the incorporation efficiency of the two virus-like NA vRNA segments encoding the reporter proteins into single progeny virions, we generated WSN-based NA-knockout recombinant influenza viruses by using reverse genetics (11) with the tandem reporter plasmids instead of a plasmid for the expression of the intact NA vRNA. At 24 h posttransfection, culture supernatants were clarified and subjected to plaque assays in Madin-Darby canine kidney (MDCK) cells. These NA-knockout viruses formed small plaques in MDCK cells as described previously (4); most of the plaques expressed fluorescent proteins at 24 to 48 h postinfection (data not shown). We then counted the GFP- and/or DsRed-positive plaques. Most of the plaques expressed only either GFP (59.3%) or DsRed (39.1%) (Fig. 1E); only a small portion (1.6%) of the plaques was positive for both GFP and DsRed (Fig. 1E). These results suggest that the two reporter virus-like RNAs competed for incorporation into individual virions.
The competitive effect of the two reporter virus-like RNAs was also assessed by using PB2 vRNA segment-based virus-like RNAs. We constructed tandem reporter plasmids for the recombinant PB2 vRNA segment (Fig. 2A to C). These plasmids encoded the 3′ and 5′ ends of the PB2 vRNA segment including 120 nucleotides of each coding sequence, which were required for efficient incorporation of the PB2 vRNA segment (15). The expression of both GFP- and DsRed-encoding virus-like RNAs in cells transfected with the tandem reporter plasmids was confirmed as described above. Similar to the results with the NA vRNA segment-based plasmids, approximately half (53.5%) of the transfected cells expressed GFP and DsRed (Fig. 2D). By using these tandem reporter plasmids instead of an intact PB2 vRNA-expressing plasmid, we generated PB2-knockout viruses by means of reverse genetics. We then counted the GFP- and/or DsRed-positive plaques formed by the transfectant viruses in PB2 protein-expressing MDCK cells that were established by using a retrovirus vector as described previously (16). Like the NA-knockout viruses, these PB2-knockout viruses mainly formed plaques expressing only either GFP (75.6%) or DsRed (23.8%); only a limited portion (0.6%) of the plaques expressed both GFP and DsRed (Fig. 2E). These results indicate that, as with the NA segment, only a single PB2 segment is incorporated into virions.
Fig 2
Fig 2 Competitive incorporation of the PB2 vRNA segment into virions. (A to C) Schematic diagram of influenza virus-like RNA constructs. Transcription cassettes for GFP (green bar in panel A) and DsRed (red bar in panel B) genes flanked by the 3′ and 5′ noncoding (white bars) and coding (black bars) sequences of the PB2 vRNA segment were cloned into RNA polymerase I promoter-driven plasmids in different configurations (panel C). (D) Ratio of fluorescent protein-expressing plasmid-transfected cells. 293T cells were transfected with PB2 vRNA segment-derived tandem reporter plasmids together with protein expression plasmids required for vRNA transcription and replication. At 24 h posttransfection, cells positive for GFP only (green bar), DsRed only (red bar), and both GFP and DsRed (yellow) were counted under a fluorescence microscope. Mean ratios of each cell population calculated from three independent experiments are shown. (E) Ratio of fluorescent protein-expressing virus-formed plaques. PB2 protein-expressing MDCK cells were infected with PB2-knockout viruses generated in cells that were transfected with a PB2 vRNA segment-derived tandem reporter plasmid, and plaque assays were performed. At 24 h postinfection, plaques positive for GFP only (green bar), DsRed only (red bar), and both GFP and DsRed (yellow) were counted under a fluorescence microscope. Mean ratios of each plaque population calculated from three independent experiments are shown.
Here, we demonstrated that two virus-like RNAs derived from identical vRNA segments competed for incorporation into progeny viruses. Although half of the cells transfected with plasmids for virus generation were positive for two reporter proteins (Fig. 1D and 2D), most of the plaques formed by the transfectant viruses were positive for only one or the other protein (Fig. 1E and 2E). These findings suggest that individual influenza virions incorporate single, not multiple, copies of homologous vRNA segments, that is, the eight distinct vRNA segments required for virus replication are present in individual virions.

ACKNOWLEDGMENTS

We thank Susan Watson for editing the manuscript.
This work was supported by ERATO (Japan Science and Technology Agency), by a grant-in-aid for Specially Promoted Research from the Ministries of Education, Culture, Sport, Science, and Technology, by a grant-in-aid from Health, Labor, and Welfare of Japan, by a Contract Research Fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, and by National Institute of Allergy and Infectious Diseases Public Health Service research grants.

REFERENCES

1.
Dos Santos Afonso E, Escriou N, Leclercq I, van der Werf S, and Naffakh N. 2005. The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment. Virology 341:34–46.
2.
Fournier E et al. 2012. A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res. 40:2197–2209.
3.
Fujii K et al. 2005. Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J. Virol. 79:3766–3774.
4.
Fujii Y, Goto H, Watanabe T, Yoshida T, and Kawaoka Y. 2003. Selective incorporation of influenza virus RNA segments into virions. Proc. Natl. Acad. Sci. U. S. A. 100:2002–2007.
5.
Gog JR et al. 2007. Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res. 35:1897–1907.
6.
Liang Y, Hong Y, and Parslow TG. 2005. cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J. Virol. 79:10348–10355.
7.
Liang Y, Huang T, Ly H, Parslow TG, and Liang Y. 2008. Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments. J. Virol. 82:229–236.
8.
Marsh GA, Hatami R, and Palese P. 2007. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J. Virol. 81:9727–9736.
9.
Marsh GA, Rabadan R, Levine AJ, and Palese P. 2008. Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J. Virol. 82:2295–2304.
10.
Muramoto Y et al. 2006. Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J. Virol. 80:2318–2325.
11.
Neumann G et al. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U. S. A. 96:9345–9350.
12.
Noda T et al. 2006. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 439:490–492.
13.
Noda T et al. 2012. Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat. Commun. 3:639.
14.
Ozawa M et al. 2007. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J. Virol. 81:30–41.
15.
Ozawa M et al. 2009. Nucleotide sequence requirements at the 5′ end of the influenza A virus M RNA segment for efficient virus replication. J. Virol. 83:3384–3388.
16.
Ozawa M et al. 2011. Replication-incompetent influenza A viruses that stably express a foreign gene. J. Gen. Virol. 92:2879–2888.
17.
Palese P and Schulman JL. 1976. Differences in RNA patterns of influenza A viruses. J. Virol. 17:876–884.
18.
Palese P and Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647–1689. In Knipe DM and Howley PM (ed), Fields virology, 5th ed. Lippincott-Raven Publishers, Philadelphia, PA.

Information & Contributors

Information

Published In

cover image Journal of Virology
Journal of Virology
Volume 86Number 1815 September 2012
Pages: 10200 - 10202
PubMed: 22740412

History

Received: 13 May 2012
Accepted: 20 June 2012
Published online: 15 September 2012

Permissions

Request permissions for this article.

Contributors

Authors

Arisa Inagaki
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan
Hideo Goto
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan
Satoshi Kakugawa
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan
Makoto Ozawa
Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan
Transboundary Animal Diseases Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan
Yoshihiro Kawaoka
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan
Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, USA
ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan

Notes

Address correspondence to Yoshihiro Kawaoka, [email protected].

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy